RUTABAGA CAPITAL MANAGEMENT LLC/MA - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RUTABAGA CAPITAL MANAGEMENT LLC/MA ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2017$10,395,000
+2.5%
178,976
-20.8%
2.39%
+10.5%
Q3 2017$10,144,000
-42.1%
226,076
-49.0%
2.16%
-33.9%
Q2 2017$17,505,000
-12.6%
443,269
-10.2%
3.27%
-1.9%
Q1 2017$20,018,000
-3.0%
493,419
-3.9%
3.33%
-5.9%
Q4 2016$20,647,000
+10.0%
513,619
-0.9%
3.54%
-0.1%
Q3 2016$18,774,000
+5.4%
518,487
-15.6%
3.55%
+6.8%
Q2 2016$17,805,000614,1873.32%
Other shareholders
HAEMONETICS CORP shareholders Q2 2017
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders